Wissam Gharib is a Cardiology physician affiliated with Mon Health Medical Center. OpenAlex indexes 22 publications with 262 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
43 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AbbottProgram year202511 paymentsResearch$47,948openpaymentsdata.cms.gov ↗
- Boston ScientificProgram year202515 paymentsResearch$43,920openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202535 payments$12,143openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.8%Beta blocker14.4%Metoprolol Succinate84%Metoprolol Tartrate10%Carvedilol7%Part D<11 patientsAngiotensin receptor blocker (ARB)10.9%Losartan Potassium71%Losartan-Hydrochlorothiazide29%Part D≥43 patients+ 13 more classes in this area
Blood & clotting
15.7%P2Y12 inhibitor10.2%Clopidogrel75%Brilinta25%Part D<11 patientsFactor Xa inhibitor4.5%Eliquis64%Xarelto36%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
5.5%Potassium supplement4.6%Potassium Chloride100%Part D≥34 patientsProton pump inhibitor0.9%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- C-119 | Renal Denervation: A Novel Treatment for Individuals with Resistant Hypertension
Journal of the Society for Cardiovascular Angiography & Interventions
2026 - THE FEASIBILITY AND SAFETY OF SAME DAY DISCHARGE FOR ALL COMERS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTIONS
Journal of the American College of Cardiology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Gregg Fonarow, MD
Ronald Reagan UCLA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”